MarketPeel
Insider Trading Intelligence
MV

Madhav Vasanthavada

ABEO
CHIEF COMMERCIAL OFFICER · ABEONA THERAPEUTICS INC. · CIK 0002106295
FILING MIX · LIFETIME17%/83%
BUYS
1
SELLS
5
TOTAL VALUE
$152.5K
COMPANIES
1
ACTIVE SINCE
Jan 2026
HOLDINGS NOW
303,229
AVG SELL PX
$5.45
TRADE KIND
SHOWING 6 / 6
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 8 pending
Forward-return performance of every backtestable P/S trade by Madhav Vasanthavada, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+100.00%-7.22%+0.57%-7.79%-7.79%
14d2+100.00%-7.88%-1.65%-6.93%-6.93%
30d2+100.00%-4.43%-0.12%-4.31%-4.31%
60d2(1 pending)+100.00%-17.54%-4.88%-12.66%-12.66%
90d2(1 pending)+0.00%+5.04%+3.23%+1.81%+1.81%
180d2(2 pending)
1y2(2 pending)
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ABEO · 303,229 shares · as of Jun 16, 2026
082,807165,615248,422331,229SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2026
2026
FLOW · 1 buys / 5 sellsCOVERAGE · 2 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Commercial Officer
222$5.67$1.3K303,229Jun 16, 2026Jun 17, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Commercial Officer
5,450$5.30$28.9K303,451Jun 9, 2026Jun 9, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Commercial Officer
4,170$5.43$22.6K308,901Jun 8, 2026Jun 9, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Commercial Officer
5,548$5.96$33.1K313,071May 11, 2026May 11, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
SALE
Chief Commercial Officer
12,610$5.29$66.7K318,619Jan 22, 2026Jan 26, 2026View →
ABEO
ABEONA THERAPEUTICS INC.
PURCHASEGRANT
Stock grant
76,621331,229Jan 20, 2026Jan 26, 2026View →
Other insiders · ABEO
Loading peer insiders…
About this filer
CIK 0002106295
ROLE
Chief Commercial Officer
PRIMARY
ABEO
COMPANIES
1
ACTIVE SINCE
Jan 2026
MARKETPEEL · /INSIDER/0002106295DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback